DARPP-32 phosphorylation opposes the behavioral effects of nicotine

Hongwen Zhu, MoonSook Lee, Fangxia Guan, Soh Agatsuma, Daniel Scott, Kevin Fabrizio, Allen A. Fienberg, Noboru Hiroi

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background: The addictive properties of nicotine are mediated via dopaminergic pathways and their post-synaptic neurons in the striatum. Because post-synaptic neurons within the striatum contain high levels of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32), we hypothesized that DARPP-32 may functionally contribute to the behavioral effects of nicotine. Methods: We examined the behavioral effects of nicotine and the phosphorylation state of DARPP-32 in wild-type (WT) and DARPP-32 knockout (KO) mice. In one experiment, we assessed voluntary nicotine intake (0-50 μg/ml) of WT and KO mice in a two-bottle choice paradigm. In a separate experiment, the motor-depressant effects of acute and repeated nicotine injections (0-.8 mg/kg, subcutaneously [SC]) were assessed. The phosphorylation of DARPP-32 at threonine34 and threonine75 were examined using Western blotting. Results: A heightened responsiveness to nicotine was seen in KO mice when compared with WT mice in oral intake and motor depression. The enhanced responsiveness in KO mice was not due to alterations in taste sensations, fluid intake, or blood nicotine or cotinine levels. Systemic injections of nicotine resulted in increased striatal DARPP-32 phosphorylation at threonine 34 and threonine75. Conclusions: DARPP-32 opposes the behavioral effects of nicotine possibly via concurrent phosphorylation at the two threonine sites.

Original languageEnglish (US)
Pages (from-to)981-989
Number of pages9
JournalBiological Psychiatry
Volume58
Issue number12
DOIs
StatePublished - Dec 15 2005

Fingerprint

Dopamine and cAMP-Regulated Phosphoprotein 32
Nicotine
Phosphorylation
Knockout Mice
Threonine
Neurons
Corpus Striatum
Cotinine
Injections
Western Blotting

Keywords

  • Addiction
  • Dependence
  • Dopamine
  • PKA
  • Plasticity
  • Striatum

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

DARPP-32 phosphorylation opposes the behavioral effects of nicotine. / Zhu, Hongwen; Lee, MoonSook; Guan, Fangxia; Agatsuma, Soh; Scott, Daniel; Fabrizio, Kevin; Fienberg, Allen A.; Hiroi, Noboru.

In: Biological Psychiatry, Vol. 58, No. 12, 15.12.2005, p. 981-989.

Research output: Contribution to journalArticle

Zhu, H, Lee, M, Guan, F, Agatsuma, S, Scott, D, Fabrizio, K, Fienberg, AA & Hiroi, N 2005, 'DARPP-32 phosphorylation opposes the behavioral effects of nicotine', Biological Psychiatry, vol. 58, no. 12, pp. 981-989. https://doi.org/10.1016/j.biopsych.2005.05.026
Zhu, Hongwen ; Lee, MoonSook ; Guan, Fangxia ; Agatsuma, Soh ; Scott, Daniel ; Fabrizio, Kevin ; Fienberg, Allen A. ; Hiroi, Noboru. / DARPP-32 phosphorylation opposes the behavioral effects of nicotine. In: Biological Psychiatry. 2005 ; Vol. 58, No. 12. pp. 981-989.
@article{3118986ab2f74361b512e2d5401fbd7b,
title = "DARPP-32 phosphorylation opposes the behavioral effects of nicotine",
abstract = "Background: The addictive properties of nicotine are mediated via dopaminergic pathways and their post-synaptic neurons in the striatum. Because post-synaptic neurons within the striatum contain high levels of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32), we hypothesized that DARPP-32 may functionally contribute to the behavioral effects of nicotine. Methods: We examined the behavioral effects of nicotine and the phosphorylation state of DARPP-32 in wild-type (WT) and DARPP-32 knockout (KO) mice. In one experiment, we assessed voluntary nicotine intake (0-50 μg/ml) of WT and KO mice in a two-bottle choice paradigm. In a separate experiment, the motor-depressant effects of acute and repeated nicotine injections (0-.8 mg/kg, subcutaneously [SC]) were assessed. The phosphorylation of DARPP-32 at threonine34 and threonine75 were examined using Western blotting. Results: A heightened responsiveness to nicotine was seen in KO mice when compared with WT mice in oral intake and motor depression. The enhanced responsiveness in KO mice was not due to alterations in taste sensations, fluid intake, or blood nicotine or cotinine levels. Systemic injections of nicotine resulted in increased striatal DARPP-32 phosphorylation at threonine 34 and threonine75. Conclusions: DARPP-32 opposes the behavioral effects of nicotine possibly via concurrent phosphorylation at the two threonine sites.",
keywords = "Addiction, Dependence, Dopamine, PKA, Plasticity, Striatum",
author = "Hongwen Zhu and MoonSook Lee and Fangxia Guan and Soh Agatsuma and Daniel Scott and Kevin Fabrizio and Fienberg, {Allen A.} and Noboru Hiroi",
year = "2005",
month = "12",
day = "15",
doi = "10.1016/j.biopsych.2005.05.026",
language = "English (US)",
volume = "58",
pages = "981--989",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "12",

}

TY - JOUR

T1 - DARPP-32 phosphorylation opposes the behavioral effects of nicotine

AU - Zhu, Hongwen

AU - Lee, MoonSook

AU - Guan, Fangxia

AU - Agatsuma, Soh

AU - Scott, Daniel

AU - Fabrizio, Kevin

AU - Fienberg, Allen A.

AU - Hiroi, Noboru

PY - 2005/12/15

Y1 - 2005/12/15

N2 - Background: The addictive properties of nicotine are mediated via dopaminergic pathways and their post-synaptic neurons in the striatum. Because post-synaptic neurons within the striatum contain high levels of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32), we hypothesized that DARPP-32 may functionally contribute to the behavioral effects of nicotine. Methods: We examined the behavioral effects of nicotine and the phosphorylation state of DARPP-32 in wild-type (WT) and DARPP-32 knockout (KO) mice. In one experiment, we assessed voluntary nicotine intake (0-50 μg/ml) of WT and KO mice in a two-bottle choice paradigm. In a separate experiment, the motor-depressant effects of acute and repeated nicotine injections (0-.8 mg/kg, subcutaneously [SC]) were assessed. The phosphorylation of DARPP-32 at threonine34 and threonine75 were examined using Western blotting. Results: A heightened responsiveness to nicotine was seen in KO mice when compared with WT mice in oral intake and motor depression. The enhanced responsiveness in KO mice was not due to alterations in taste sensations, fluid intake, or blood nicotine or cotinine levels. Systemic injections of nicotine resulted in increased striatal DARPP-32 phosphorylation at threonine 34 and threonine75. Conclusions: DARPP-32 opposes the behavioral effects of nicotine possibly via concurrent phosphorylation at the two threonine sites.

AB - Background: The addictive properties of nicotine are mediated via dopaminergic pathways and their post-synaptic neurons in the striatum. Because post-synaptic neurons within the striatum contain high levels of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32), we hypothesized that DARPP-32 may functionally contribute to the behavioral effects of nicotine. Methods: We examined the behavioral effects of nicotine and the phosphorylation state of DARPP-32 in wild-type (WT) and DARPP-32 knockout (KO) mice. In one experiment, we assessed voluntary nicotine intake (0-50 μg/ml) of WT and KO mice in a two-bottle choice paradigm. In a separate experiment, the motor-depressant effects of acute and repeated nicotine injections (0-.8 mg/kg, subcutaneously [SC]) were assessed. The phosphorylation of DARPP-32 at threonine34 and threonine75 were examined using Western blotting. Results: A heightened responsiveness to nicotine was seen in KO mice when compared with WT mice in oral intake and motor depression. The enhanced responsiveness in KO mice was not due to alterations in taste sensations, fluid intake, or blood nicotine or cotinine levels. Systemic injections of nicotine resulted in increased striatal DARPP-32 phosphorylation at threonine 34 and threonine75. Conclusions: DARPP-32 opposes the behavioral effects of nicotine possibly via concurrent phosphorylation at the two threonine sites.

KW - Addiction

KW - Dependence

KW - Dopamine

KW - PKA

KW - Plasticity

KW - Striatum

UR - http://www.scopus.com/inward/record.url?scp=29044435893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29044435893&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2005.05.026

DO - 10.1016/j.biopsych.2005.05.026

M3 - Article

VL - 58

SP - 981

EP - 989

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 12

ER -